ImaginAb, Inc., announces that it has entered into an agreement to sell a pipeline of next-generation therapeutic candidates, ...

Despite a 15% drop in the SPDR S&P Biotech ETF, insider buying presents opportunities. Read why these small and mid-cap ...

Stifel has initiated coverage of Cytokinetics (CYTK) with a buy rating, citing its drug aficamten, valuation and upcoming ...

Stifel Nicolaus analyst Cole McGill maintained a Buy rating on ioneer Limited (GSCCF – Research Report) today and set a price target of A$0.40.

Shake Shack (NYSE:SHAK – Get Free Report) had its price objective lowered by equities researchers at Stifel Nicolaus from ...

Lightbridge Corporation (LTBR), a management consulting services firm with a market capitalization of approximately $89 ...

Stifel Nicolaus analyst David Grossman maintained a Hold rating on Health Catalyst (HCAT – Research Report) today and set a price target of ...

Schneider National (NYSE:SNDR – Get Free Report) had its price target boosted by research analysts at Stifel Nicolaus from ...

Quantum computing stocks have majorly captivated investors in 2025. Still, the road to widespread adoption has been dogged by ...

With the advent of the digital age, tech-minded thieves, scammers, and hackers found a panoply of new prospective victims. As digital tools became routine within the government and industrial sectors, ...

Stifel initiated coverage of Structure Therapeutics (GPCR) with a Buy rating and $50 price target Structure aims to expand the reach of metabolic treatments across the large, heterogeneous obesity ...

We recently published a list of Top 10 AI Stocks on Wall Street’s Radar. In this article, we are going to take a look at where Astera Labs, Inc. (NASDAQ:ALAB) stands against other AI stocks on Wall ...